Frazier Life Sciences Management, L.P. Deciphera Pharmaceuticals, Inc. Transaction History

Frazier Life Sciences Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $5.89 Million - $7.53 Million	434,037 Added 42.48%	1,455,837 $22.9 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $6.59 Million - $10.8 Million	651,800 Added 176.16%	1,021,800 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $4.91 Million - $5.91 Million	370,000 New	370,000 $5.21 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.